Laurus Labs Ltd. Financials

NSE BSE

15:57 Jul 31

Laurus Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

874.35

-7.10 (-0.81%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

874.35

-7.10 (-0.81%)
15:57 Jul 31

Quality

64/100
High Financial Strength

Valuation

34/100
Mid Valuation

Technical

71/100
Technically Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	4935.57	6040.55	5040.83	5553.96	5928.62
Operating Expenses +	3513.14	4448.36	4263.33	4498.68	4662.41
Raw Material	2414.94	2752.28	2533.3	2533.91	2577.1
Increase Decrease in Cost	-221.17	22.04	-100.88	-55.93	1.38
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	501.53	580.64	639.93	719.52	760.34
Miscellaneous Expenses	1109.46	1404.82	1412.82	1511.9	1323.59
Operating Profit	1422.43	1592.19	777.5	1055.28	1266.21
Other Income	13.58	6	26.34	59.93	83.02
Depreciation	251.49	324.08	384.58	430.09	440.87
Interest	100.67	165.17	182.9	200.83	218.31
Profit before tax and exceptio..	1083.85	1108.94	236.36	484.29	690.05
Exceptional Items	0	0	0	0	0
PBT	1083.85	1108.94	236.36	484.29	690.05
Provision for Taxation	251.42	312.3	68.15	129.88	186.77
Net Profit	832.43	796.64	168.21	354.41	503.28
NET Profit after MI	827.52	790.11	160.55	358.32	508.83
EPS	15.42	14.64	2.97	6.64	9.44
Operating Profit Margin (%)	28.82	26.36	15.42	19	21.36
Net Profit Margin (%)	16.77	13.08	3.19	6.45	8.58

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	27.60	27.60	27.60	27.20	27.20
FII	25.70	25.50	25.60	26.10	25.70
MF	7.80	6.90	7.60	8.20	9.20
Others	4.10	4.90	5.10	4.80	4.30

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: